1. Home
  2. HXHX vs DCOY Comparison

HXHX vs DCOY Comparison

Compare HXHX & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.42

Market Cap

7.1M

Sector

Industrials

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$7.60

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HXHX
DCOY
Founded
2003
N/A
Country
China
United States
Employees
85
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
4.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HXHX
DCOY
Price
$0.42
$7.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
2.7M
79.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.53
52 Week High
$2.15
$9.09

Technical Indicators

Market Signals
Indicator
HXHX
DCOY
Relative Strength Index (RSI) 39.89 83.76
Support Level $0.34 $0.61
Resistance Level $0.55 $9.09
Average True Range (ATR) 0.04 0.28
MACD -0.01 0.80
Stochastic Oscillator 8.63 81.42

Price Performance

Historical Comparison
HXHX
DCOY

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Share on Social Networks: